However, in mice subjected to 5/6 nephrectomy and continuous low-dose angiotensin II infusion, wild-type mice, but not TLR4 mutant mice, develop progressive CKD [55], suggesting that a TLR4 ligand, such as eNAPRT, could contribute to progressive renal disease. This evidence concerns the gene TLR4 and kidney disorder.